Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02QMU
|
||||
| Former ID |
DNC014368
|
||||
| Drug Name |
9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530920] | ||
| Formula |
C28H27BrN2O5
|
||||
| Canonical SMILES |
COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OCCCC<br />OC6=CC=CC=N6.[Br-]
|
||||
| InChI |
1S/C28H27N2O5.BrH/c1-31-24-8-7-19-14-23-21-16-26-25(34-18-35-26)15-20(21)9-11-30(23)17-22(19)28(24)33-13-5-4-12-32-27-6-2-3-10-29-27;/h2-3,6-8,10,14-17H,4-5,9,11-13,18H2,1H3;1H/q+1;/p-1
|
||||
| InChIKey |
NOZBPUHZHLKIBG-UHFFFAOYSA-M
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [530920] | |
| Acetylcholinesterase | Target Info | Inhibitor | [530920] | ||
| KEGG Pathway | Glycerophospholipid metabolism | ||||
| Cholinergic synapse | |||||
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| Pathway Interaction Database | ATF-2 transcription factor network | ||||
| PathWhiz Pathway | Phospholipid Biosynthesis | ||||
| References | |||||